<!DOCTYPE html><html><head><title>Diagnosis and management of attention deficit hyperactivity disorder (ADHD) in primary care for school-age children and adolescents: percentage of patients treated with psychostimulant medication for the diagnosis of ADHD for the first time whose medical record contains documentation of a follow-up visit within 30 days of medication initiation that includes height, weight, a discussion of medication, a discussion of school progress and a care plan.</title><link rel="stylesheet" type="text/css" href="style.css"></head><body><div class='section'>
<h2>General
</h2>
<div class='field field_text'>
<h3>
Title
</h3>
<div class='FieldValue'>
<div class="content_title">Diagnosis and management of attention deficit hyperactivity disorder (ADHD) in primary care for school-age children and adolescents: percentage of patients treated with psychostimulant medication for the diagnosis of ADHD for the first time whose medical record contains documentation of a follow-up visit within 30 days of medication initiation that includes height, weight, a discussion of medication, a discussion of school progress and a care plan.</div>
</div>

</div>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Institute for Clinical Systems Improvement (ICSI). Quality improvement support: diagnosis and management of attention deficit hyperactivity disorder in primary care for school-age children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2012 Mar. 8 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Measure Domain
</h2>
<div class='field field_picklist-one'>
<h3>
Primary Measure Domain
</h3>
<div class='FieldValue'>
Clinical Quality Measures: Process
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Secondary Measure Domain
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>

</div>
<div class='section'>
<h2>Brief Abstract
</h2>
<div class='field field_text'>
<h3>
Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This measure is used to assess the percentage of patients age 4 through 18 years treated with psychostimulant medication for the diagnosis of attention deficit hyperactivity disorder (ADHD) for the first time whose medical record contains documentation of a follow-up visit within 30 days of medication initiation that includes height, weight, a discussion of medication, a discussion of school progress and a care plan.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Rationale
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The priority aim addressed by this measure is to improve the primary care use of U.S. Food and Drug Administration (FDA)-approved attention deficit hyperactivity disorder (ADHD) medications with indications for management of patients with ADHD.</p>
<p>The American Academy of Pediatrics (AAP) recommendation is fully endorsed by the Institute for Clinical Systems Improvement (ICSI) ADHD work group:</p>
<p>"For preschool-aged children (4 to 5 years of age), the primary care clinician should prescribe evidence-based parent and/or teacher-administered behavior therapy as the first line of treatment, and may prescribe methylphenidate if the behavior interventions do not provide significant improvement and there is moderate-to-severe continuing disturbance in the child's function. In areas in which evidence-based behavioral treatments are not available, the clinician needs to weigh the risks of starting medication at an early age against the harm of delaying diagnosis and treatment."</p>
<p>"For elementary school-aged children (6 to 11 years of age), the primary care clinician should prescribe FDA approved medications for ADHD and/or evidence based parent and/or teacher administered behavior therapy as treatment for ADHD, preferably both. The evidence is particularly strong for stimulant medications and sufficient but less strong for atomoxetine, extended-release guanfacine, and extended release Clonidine (in that order). The school environment, program, or placement is a part of any treatment plan."</p>
<p>"For adolescents (12 to 18 years of age), the primary care clinician should prescribe FDA-approved medications for ADHD with the assent of the adolescent and may prescribe behavior therapy as treatment for ADHD, preferably both."</p></div>
</div>

</div>
<div class='field field_citation'>
<h3>
Evidence for Rationale
</h3>
<div class='FieldValue'>
<table><tr><td>Institute for Clinical Systems Improvement (ICSI). Diagnosis and management of attention deficit hyperactivity disorder in primary care for school-age children and adolescents. Endorsement. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 3 p. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Institute for Clinical Systems Improvement (ICSI). Quality improvement support: diagnosis and management of attention deficit hyperactivity disorder in primary care for school-age children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2012 Mar. 8 p. </td></tr></table>
</div>
<div class='FieldValue'>
<table><tr><td>Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, Ganiats TG, Kaplanek B, Meyer B, Perrin J, Pierce K, Reiff M, Stein MT, Visser S. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011 Nov;128(5):1007-22. [70 references] <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=22003063" target="_blank">PubMed</a></td></tr></table>
</div>

</div>
<div class='field field_text'>
<h3>
Primary Health Components
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Attention deficit hyperactivity disorder (ADHD); psychostimulant medication; follow-up visit; children; adolescents</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Number of patients newly diagnosed with attention deficit hyperactivity disorder (ADHD) and prescribed psychostimulant medication (see the related "Denominator Inclusions/Exclusions" field)</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Description
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Number of patients diagnosed with attention deficit hyperactivity disorder (ADHD) and prescribed psychostimulant medication for the first time whose medical record contains documentation of a follow-up visit within 30 days of medication initiation and the following components were discussed at the visit: height, weight, medication, school progress and a care plan </p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Evidence Supporting the Measure
</h2>
<div class='field field_picklist-choice'>
<h3>
Type of Evidence Supporting the Criterion of Quality for the Measure
</h3>
<div class='FieldValue'>
A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence
</div>

</div>
<div class='field field_text'>
<h3>
Additional Information Supporting Need for the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Extent of Measure Testing
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>State of Use of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
State of Use
</h3>
<div class='FieldValue'>
Current routine use
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Current Use
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Application of the Measure in its Current Use
</h2>
<div class='field field_picklist-choice'>
<h3>
Measurement Setting
</h3>
<div class='FieldValue'>
Ambulatory/Office-based Care
</div>
<div class='FieldValue'>
Transition
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Type of Care Coordination
</h3>
<div class='FieldValue'>
Coordination between providers and patient/caregiver
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Professionals Involved in Delivery of Health Services
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Least Aggregated Level of Services Delivery Addressed
</h3>
<div class='FieldValue'>
Clinical Practice or Public Health Sites
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Statement of Acceptable Minimum Sample Size
</h3>
<div class='FieldValue'>
Unspecified
</div>

</div>
<div class='field field_text'>
<h3>
Target Population Age
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Age 4 to 18 years</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Target Population Gender
</h3>
<div class='FieldValue'>
Either male or female
</div>

</div>

</div>
<div class='section'>
<h2>National Strategy for Quality Improvement in Health Care
</h2>
<div class='field field_text'>
<h3>
National Quality Strategy Aim
</h3>
<div class='FieldValue'>
<ul><li>Better Care</li></ul>
</div>

</div>
<div class='field field_text'>
<h3>
National Quality Strategy Priority
</h3>
<div class='FieldValue'>
<ul><li>Effective Communication and Care Coordination</li><li>Prevention and Treatment of Leading Causes of Mortality</li></ul>
</div>

</div>

</div>
<div class='section'>
<h2>Institute of Medicine (IOM) National Health Care Quality Report Categories
</h2>
<div class='field field_picklist-choice'>
<h3>
IOM Care Need
</h3>
<div class='FieldValue'>
Living with Illness
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
IOM Domain
</h3>
<div class='FieldValue'>
Effectiveness
</div>

</div>

</div>
<div class='section'>
<h2>Data Collection for the Measure
</h2>
<div class='field field_text'>
<h3>
Case Finding Period
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The time frame pertaining to data collection is monthly.</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Denominator Sampling Frame
</h3>
<div class='FieldValue'>
Patients associated with provider
</div>

</div>
<div class='field field_picklist-choice'>
<h3>
Denominator (Index) Event or Characteristic
</h3>
<div class='FieldValue'>
Clinical Condition
</div>
<div class='FieldValue'>
Patient/Individual (Consumer) Characteristic
</div>
<div class='FieldValue'>
Therapeutic Intervention
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Denominator Time Window
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Denominator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions </strong><br />
Number of patients newly diagnosed with attention deficit hyperactivity disorder (ADHD) and prescribed psychostimulant medication</p>
<p>For this measure, count medication initiation date as the start of the 30-day period.</p>
<p class="Note"><strong>Population Definition</strong>: Patients age 4 through 18 years.</p>
<p class="Note"><strong>Data Collection</strong>:</p>
<ul class="Note" style="list-style-type: disc;">
    <li>Query electronic medical records (EMR) for all patients diagnosed with ADHD and prescribed psychostimulant medication. </li>
    <li>Recognize that the date of initiation of medication may be different than the date of dispensing. </li>
    <li>Depending upon the size of the medical group's ADHD population, data may be collected on a less frequent basis. </li>
</ul>
<p><strong>Exclusions </strong><br />
Unspecified </p></div>
</div>

</div>
<div class='field field_picklist-choice-4'>
<h3>
Exclusions/Exceptions
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_text'>
<h3>
Numerator Inclusions/Exclusions
</h3>
<div class='FieldValue'>
<div class="content_para"><p><strong>Inclusions</strong><br />
Number of patients diagnosed with attention deficit hyperactivity disorder (ADHD) and prescribed psychostimulant medication for the first time whose medical record contains documentation of a follow-up visit within 30 days of medication initiation and the following components were discussed at the visit: height, weight, medication, school progress and a care plan</p>
<p><strong>Exclusions</strong> <br />
Unspecified</p></div>
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Numerator Search Strategy
</h3>
<div class='FieldValue'>
Fixed time period or point in time
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Data Source
</h3>
<div class='FieldValue'>
Electronic health/medical record
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Type of Health State
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_text'>
<h3>
Instruments Used and/or Associated with the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Computation of the Measure
</h2>
<div class='field field_picklist-one'>
<h3>
Measure Specifies Disaggregation
</h3>
<div class='FieldValue'>
Does not apply to this measure
</div>

</div>
<div class='field field_picklist-many'>
<h3>
Scoring
</h3>
<div class='FieldValue'>
Rate/Proportion
</div>

</div>
<div class='field field_picklist-one'>
<h3>
Interpretation of Score
</h3>
<div class='FieldValue'>
Desired value is a higher score
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Allowance for Patient or Population Factors
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>
<div class='field field_picklist-choice-3'>
<h3>
Standard of Comparison
</h3>
<div class='FieldValue'>
not defined yet
</div>

</div>

</div>
<div class='section'>
<h2>Identifying Information
</h2>
<div class='field field_text'>
<h3>
Original Title
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Percentage of patients treated with psychostimulant medication for the diagnosis of ADHD for the first time whose medical record contains documentation of a follow-up visit within 30 days of medication initiation that include height, weight, a discussion of medication, a discussion of school progress and a care plan.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Collection Name
</h3>
<div class='FieldValue'>
Diagnosis and Management of Attention Deficit Hyperactivity Disorder in Primary Care for School-age Children and Adolescents
</div>

</div>
<div class='field field_orglist'>
<h3>
Submitter
</h3>
<div class='FieldValue'>
Institute for Clinical Systems Improvement - Nonprofit Organization
</div>

</div>
<div class='field field_orglist-p'>
<h3>
Developer
</h3>
<div class='FieldValue'>
Institute for Clinical Systems Improvement - Nonprofit Organization
</div>

</div>
<div class='field field_text'>
<h3>
Funding Source(s)
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The Institute for Clinical Systems Improvement's (ICSI's) work is funded by the annual dues of the member medical groups and five sponsoring health plans in Minnesota and Wisconsin.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Composition of the Group that Developed the Measure
</h3>
<div class='FieldValue'>
<div class="content_para"><p><em>Work Group Members</em>: Colleen L. Dobie, MS, RN, CNP, PMHS (<em>Work Group Leader</em>); W. Brooks Donald, MD, MPH; Karen Elhai, MD, MPH; JoAnne Hoffman-Jecha, MD; John Huxsahl, MD; Robert Karasov, MD (<em>Work Group Leader</em>); Carolyn Kippes, MD; Lynne Steiner, MD; Mary T. Wild Crea, MD</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Financial Disclosures/Other Potential Conflicts of Interest
</h3>
<div class='FieldValue'>
<div class="content_para"><p>The Institute for Clinical Systems Improvement (ICSI) has long had a policy of transparency in declaring potential conflicting and competing interests of all individuals who participate in the development, revision and approval of ICSI guidelines and protocols. </p>
<p>In 2010, the ICSI Conflict of Interest Review Committee was established by the Board of Directors to review all disclosures and make recommendations to the board when steps should be taken to mitigate potential conflicts of interest, including recommendations regarding removal of work group members. This committee has adopted the Institute of Medicine Conflict of Interest standards as outlined in the report Clinical Practice Guidelines We Can Trust (2011). </p>
<p>Where there are work group members with identified potential conflicts, these are disclosed and discussed at the initial work group meeting. These members are expected to recuse themselves from related discussions or authorship of related recommendations, as directed by the Conflict of Interest committee or requested by the work group.</p>
<p>The complete ICSI policy regarding Conflicts of Interest is available at the <a href="https://www.icsi.org/_asset/fwsfmi/coi_policyletter.pdf" title="ICSI Web site">ICSI Web site</a>.</p>
<p><strong>2013-2014 Institute for Clinical Systems Improvement (ICSI) Attention Deficit Hyperactivity Disorder (ADHD): Diagnosis and Management of ADHD in Primary Care for School-age Children and Adolescent Work Group, and Statement of Declared Potential Conflicts of Interest</strong></p>
<p><strong>Colleen L. Dobie, MS, RN, CNP, PMHS (Work Group Leader) </strong><br />
Pediatric Nurse Practitioner, Pediatrics, Allina Medical Clinic <br />
National, Regional, Local Committee Affiliations: National Association of Pediatric Nurse Practitioners Expert Panel Psychosocial/Mental Health (ADHD) <br />
Guideline Related Activities: None <br />
Research Grants: None <br />
Financial/Non-Financial Conflicts of Interest: Received honorarium for presentation on ADHD medications to Washington County School District </p>
<p><strong>W. Brooks Donald, MD, MPH (Work Group Member)</strong> <br />
Developmental Behavioral Specialist, Pediatrics, HealthPartners Medical Group and Regions Hospital <br />
National, Regional, Local Committee Affiliations: Learning Disabilities Association of Minnesota Board Member <br />
Guideline Related Activities: None <br />
Research Grants: None <br />
Financial/Non-Financial Conflicts of Interest: None </p>
<p><strong>Karen Elhai, MD, MPH (Work Group Member) </strong><br />
Pediatrician, Pediatrics, HealthPartners Medical Group and Regions Hospital <br />
National, Regional, Local Committee Affiliations: None <br />
Guideline Related Activities: None <br />
Research Grants: None <br />
Financial/Non-Financial Conflicts of Interest: None</p>
<p><strong>JoAnne Hoffman-Jecha, MD (Work Group Member)</strong> <br />
Director of Mental Health Services, Pediatrics, South Lake Pediatrics <br />
National, Regional, Local Committee Affiliations: None <br />
Guideline Related Activities: Served on the ADHD, Anxiety and Depression toolkit work groups with Children's Physician Network <br />
Research Grants: None <br />
Financial/Non-Financial Conflicts of Interest: None </p>
<p><strong>John Huxsahl, MD (Work Group Member) </strong><br />
Physician, Psychiatry, Mayo Clinic <br />
National, Regional, Local Committee Affiliations: None <br />
Guideline Related Activities: None <br />
Research Grants: None <br />
Financial/Non-Financial Conflicts of Interest: None</p>
<p><strong>Robert Karasov, MD (Work Group Leader)</strong> <br />
Pediatrician, Pediatrics, Park Nicollet Health Services <br />
National, Regional, Local Committee Affiliations: None <br />
Guideline Related Activities: ICSI Board Member <br />
Research Grants: None <br />
Financial/Non-Financial Conflicts of Interest: None</p>
<p><strong>Carolyn Kippes, MD (Work Group Member)</strong> <br />
Medical Director, Developmental and Behavioral Pediatrics, Park Nicollet Health Services <br />
National, Regional, Local Committee Affiliations: None <br />
Guideline Related Activities: None <br />
Research Grants: None <br />
Financial/Non-Financial Conflicts of Interest: None </p>
<p><strong>Lynne Steiner, MD (Work Group Member) </strong><br />
Physician, Family Medicine, HealthPartners Medical Group and Regions Hospital <br />
National, Regional, Local Committee Affiliations: None <br />
Guideline Related Activities: None <br />
Research Grants: None <br />
Financial/Non-Financial Conflicts of Interest: None</p>
<p><strong>Mary T. Wild Crea, MD (Work Group Member)</strong> <br />
Pediatrician, Pediatrics, Fairview Health Services <br />
National, Regional, Local Committee Affiliations: None <br />
Guideline Related Activities: None <br />
Research Grants: None <br />
Financial/Non-Financial Conflicts of Interest: None</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Adaptation
</h3>
<div class='FieldValue'>
<div class="content_para"><p><span style="color: #333333;">This measure was not adapted from another source.</span></p></div>
</div>

</div>
<div class='field field_date'>
<h3>
Date of Most Current Version in NQMC
</h3>
<div class='FieldValue'>
2012 Mar
</div>

</div>
<div class='field field_text'>
<h3>
Measure Maintenance
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Date of Next Anticipated Revision
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Unspecified</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This is the current release of the measure.</p>
<p>The measure developer reaffirmed the currency of this measure in January 2016.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Measure Availability
</h3>
<div class='FieldValue'>
<div class="content_para"><p>Source available from the <a href="https://www.icsi.org/_asset/j0bww5/ADHDAimsMeas.pdf" title="ICSI Web site">Institute for Clinical Systems Improvement (ICSI) Web site</a>.</p>
<p>For more information, contact ICSI at 8009 34th Avenue South, Suite 1200, Bloomington, MN 55425; Phone: 952-814-7060; Fax: 952-858-9675; Web site: <a href="http://www.icsi.org" title="ICSI Web site">www.icsi.org</a>; E-mail: <a href="mailto:icsi.info@icsi.org">icsi.info@icsi.org</a>.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
NQMC Status
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary was completed by ECRI Institute on April 27, 2015.</p>
<p>The information was reaffirmed by the measure developer on January 13, 2016.</p></div>
</div>

</div>
<div class='field field_text'>
<h3>
Copyright Statement
</h3>
<div class='FieldValue'>
<div class="content_para"><p>This NQMC summary (abstracted Institute for Clinical Systems Improvement [ICSI] Measure) is based on the original measure, which is subject to the measure developer's copyright restrictions.</p>
<p>The abstracted ICSI Measures contained in this Web site may be downloaded by any individual or organization. If the abstracted ICSI Measures are downloaded by an individual, the individual may not distribute copies to third parties. </p>
<p>If the abstracted ICSI Measures are downloaded by an organization, copies may be distributed to the organization's employees but may not be distributed outside of the organization without the prior written consent of the Institute for Clinical Systems Improvement, Inc. </p>
<p>All other copyright rights in the abstracted ICSI Measures are reserved by the Institute for Clinical Systems Improvement, Inc. The Institute for Clinical Systems Improvement, Inc. assumes no liability for any adaptations or revisions or modifications made to the abstracts of the ICSI Measures.</p></div>
</div>

</div>

</div>
<div class='section'>
<h2>Production
</h2>
<div class='field field_citation'>
<h3>
Source(s)
</h3>
<div class='FieldValue'>
<table><tr><td>Institute for Clinical Systems Improvement (ICSI). Quality improvement support: diagnosis and management of attention deficit hyperactivity disorder in primary care for school-age children and adolescents. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2012 Mar. 8 p. </td></tr></table>
</div>

</div>

</div>
<div class='section'>
<h2>Disclaimer
</h2>
<div class='field field_text'>
<h3>
NQMC Disclaimer
</h3>
<div class='FieldValue'>
<p>The National Quality Measures Clearinghouseâ„¢ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href="/help-and-about/summaries/inclusion-criteria">NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p>
</div>

</div>

</div>
</body></html>